Skip to main content

Advertisement

SpringerLink
Log in

Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults

  • Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of review

Evidence-based treatments for prediabetes can prevent and delay the development of type 2 diabetes in adults. In this review, we propose a framework for population-based diabetes prevention that links screening and prevention activities across key stakeholders. We also discuss gaps in current practice, while highlighting opportunities to improve diabetes screening and prevention efforts population-wide.

Recent findings

Awareness of diabetes risk is low, and many adults with prediabetes are not identified through existing screening efforts. Accumulating evidence and policies support expansion of the Diabetes Prevention Program (DPP) into clinical and community settings. However, the infrastructure to facilitate referrals and promote data exchange among patients, clinical settings, and community-based DPP programs is lacking.

Summary

Development of evidence-driven, scalable processes for assessing diabetes risk, screening eligible adults, and delivering preventive treatments are needed to effectively improve the glycemic health of the US adult population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates and Its Burden in the United States. In: The U.S. Department of Health and Human Services, editor. Atlanta, GA. 2017.

  2. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370(16):1514–23. https://doi.org/10.1056/NEJMoa1310799.

    Article  CAS  PubMed  Google Scholar 

  3. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89. https://doi.org/10.1056/NEJMoa0806470.

    Article  CAS  Google Scholar 

  4. Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78(3):305–12.

    Article  Google Scholar 

  5. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance implications for care. Diabetes Care. 2007;30(3):753–9.

    Article  CAS  Google Scholar 

  6. •• Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988–2012. JAMA. 2015;314(10):1021–9. https://doi.org/10.1001/jama.2015.10029. This study of NHANES data estimates trends in diabetes prevalence among U.S. adults over more than 2 decades.

    Article  CAS  PubMed  Google Scholar 

  7. Centers for Disease Control and Prevention. Awareness of prediabetes--United States, 2005–2010. MMWR Morb Mortal Wkly Rep. 2013;62(11):209.

    Google Scholar 

  8. Pan XR, Li G, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study. Diabetes Care. 1997;20(4):537–44. https://doi.org/10.2337/diacare.20.4.537.

    Article  CAS  PubMed  Google Scholar 

  9. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50. https://doi.org/10.1056/NEJM200105033441801.

    Article  CAS  PubMed  Google Scholar 

  10. •• Knowler W, Barrett-Connor E, Fowler S, Hamman RF, Lachin J, Walker E, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. https://doi.org/10.1056/NEJMoa012512. This seminal clinical trial tested the comparative efficacy of the Diabetes Prevention Program lifestyle intervention vs. metformin vs. placebo in adults with prediabetes, providing most of the data about diabetes prevention in U.S. adults.

    Article  CAS  PubMed  Google Scholar 

  11. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar A, Vijay V. The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–97. https://doi.org/10.1007/s00125-005-0097-z.

    Article  CAS  PubMed  Google Scholar 

  12. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study: a 20-year follow-up study. Lancet. 2008;371(9626):1783–9. https://doi.org/10.1016/s0140-6736(08)60766-7.

    Article  PubMed  Google Scholar 

  13. •• Knowler W, Fowler S, Hamman R, Christophi C, Hoffman H, Brenneman A, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677. https://doi.org/10.1016/S0140-6736(09)61457-4. This follow-up study of participants in the Diabetes Prevention Program clinical trial demonstrated durable reductions in diabetes incidence with both intensive lifestyle intervention and metformin.

    Article  PubMed  Google Scholar 

  14. Gong Q, Gregg EW, Wang J, An Y, Zhang P, Yang W, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing diabetes prevention outcome study. Diabetologia. 2011;54(2):300–7. https://doi.org/10.1007/s00125-010-1948-9.

    Article  CAS  PubMed  Google Scholar 

  15. Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing diabetes prevention study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2(6):474–80. https://doi.org/10.1016/s2213-8587(14)70057-9.

    Article  PubMed  Google Scholar 

  16. Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the diabetes prevention program outcomes study. Lancet Diabetes Endocrinol. 2015;3(11):866–75. https://doi.org/10.1016/s2213-8587(15)00291-0.

    Article  PubMed Central  Google Scholar 

  17. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142(5):323–32.

    Article  Google Scholar 

  18. •• Hafez D, Fedewa A, Moran M, O’Brien M, Ackermann R, Kullgren JT. Workplace interventions to prevent type 2 diabetes mellitus: a narrative review. Curr Diab Rep. 2017;17(2):9. https://doi.org/10.1007/s11892-017-0840-0. The paper reviewed the literature on employer-based programs aimed at preventing type 2 diabetes among adults, both those following the Diabetes Prevention Program curriculum and alternate intervention models.

    Article  PubMed  PubMed Central  Google Scholar 

  19. • American Diabetes Association. Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S1–S150. This paper outlines expert guidelines for diabetes screening, prevention, and management that are updated annually.

    Google Scholar 

  20. Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, et al. American Association of Clinical Endocrinologists and American College of endocrinology—clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract. 2015;21(Suppl 1):1–87. https://doi.org/10.4158/ep15672.gl.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Centers for Medicare & Medicaid Services. Medicare Provides Coverage of Diabetes Screening Tests. Medicare-Learning-Network-MLN, American Medical Association, Baltimore, MD. 2018. https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/se0821.pdf. Accessed July 31 2018.

  22. Lenters-Westra E, Slingerland RJ. Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. Clin Chem. 2014;60(8):1062–72. https://doi.org/10.1373/clinchem.2014.224311.

    Article  CAS  PubMed  Google Scholar 

  23. Hirst JA, McLellan JH, Price CP, English E, Feakins BG, Stevens RJ, et al. Performance of point-of-care HbA1c test devices: implications for use in clinical practice—a systematic review and meta-analysis. Clin Chem Lab Med. 2017;55(2):167–80. https://doi.org/10.1515/cclm-2016-0303.

    Article  CAS  PubMed  Google Scholar 

  24. •• Bowen ME, Xuan L, Lingvay I, Halm EA. Performance of a random glucose case-finding strategy to detect undiagnosed diabetes. Am J Prev Med. 2017;52(6):710–6. https://doi.org/10.1016/j.amepre.2017.01.023. This analysis of NHANES data examines the clinical performance (i.e. sensitivity and specificity) of using random glucose to identify cases of undiagnosed diabetes and compares performance with commonly used U.S. diabetes screening guidelines.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Steyerberg EW. Clinical prediction models : a practical approach to development, validation, and updating. New York, NY: Springer; 2009.

    Book  Google Scholar 

  26. American Diabetes Association. Diabetes Risk Test. American Diabetes Association, Alexandria, VA. 2018. http://main.diabetes.org/dorg/PDFs/risk-test-paper-version.pdf. . Accessed July 26 2018.

  27. Bang H, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, Callahan MA, et al. Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med. 2009;151:775–83. https://doi.org/10.7326/0003-4819-151-11-200912010-00005.

    Article  PubMed  PubMed Central  Google Scholar 

  28. National Diabetes Prevention Program. CDC prediabetes screening test. Centers for Disease Control and Prevention 2016. http://www.cdc.gov/diabetes/prevention/pdf/prediabetestest.pdf. Accessed July 31 2018.

  29. Bullard KM, Ali MK, Imperatore G, Geiss LS, Saydah SH, Albu JB, et al. Receipt of glucose testing and performance of two US diabetes screening guidelines, 2007-2012. PLoS One. 2015;10(4):e0125249. https://doi.org/10.1371/journal.pone.0125249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. •• O'Brien MJ, Bullard KM, Zhang Y, Gregg EW, Carnethon MR, Kandula NR, et al. Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes. J Gen Intern Med. 2018; https://doi.org/10.1007/s11606-018-4436-4. This analysis of NHANES data examines the clinical performance of the 2015 USPSTF screening criteria for identifying U.S. adults with prediabetes and diabetes, including estimates of sensitivity and specificity by racial/ethnic groups.

    Article  Google Scholar 

  31. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham offspring study. Arch Intern Med. 2007;167(10):1068–74. https://doi.org/10.1001/archinte.167.10.1068.

    Article  PubMed  Google Scholar 

  32. Mann DM, Bertoni AG, Shimbo D, Carnethon MR, Chen H, Jenny NS, et al. Comparative validity of 3 diabetes mellitus risk prediction scoring models in a multiethnic US cohort. Am J Epidemiol. 2010;171(9):980–8. https://doi.org/10.1093/aje/kwq030.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW. Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45 to 64 years. Ann Intern Med. 2009;150(11):741.

    Article  Google Scholar 

  34. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, et al. Identifying individuals at high risk for diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28(8):2013–8.

    Article  Google Scholar 

  35. Mainous AG 3rd, Diaz VA, Everett CJ. Assessing risk for development of diabetes in young adults. Ann Fam Med. 2007;5(5):425–9. https://doi.org/10.1370/afm.705.

    Article  PubMed  PubMed Central  Google Scholar 

  36. • Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011;343:d7163. https://doi.org/10.1136/bmj.d7163. This systematic review of diabetes risk models evaluates the large body of literature on predicting diabetes risk, while highlighting opportunities and challenges to their implementation in practice.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Collins GS, Mallett S, Omar O, Yu LM. Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. 2011;9:103. https://doi.org/10.1186/1741-7015-9-103.

    Article  PubMed  PubMed Central  Google Scholar 

  38. American Medical Association. Prevent Diabetes STAT. 2015. https://preventdiabetesstat.org/. Accessed July 26 2018.

  39. Nhim K, Khan T, Gruss SM, Wozniak G, Kirley K, Schumacher P, et al. Primary care providers' prediabetes screening, testing, and referral behaviors. Am J Prev Med. 2018;55(2):e39–47. https://doi.org/10.1016/j.amepre.2018.04.017.

    Article  PubMed  Google Scholar 

  40. Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011;343:d7163.

    Article  Google Scholar 

  41. Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care. 2004;27(1):9–12.

    Article  Google Scholar 

  42. • O'Brien MJ, Lee JY, Carnethon MR, Ackermann RT, Vargas MC, Hamilton A, et al. Detecting dysglycemia using the 2015 United States Preventive Services Task Force Screening Criteria: a cohort analysis of community health center patients. PLoS Med. 2016;13(7):e1002074. https://doi.org/10.1371/journal.pmed.1002074. This national analysis of EHR data from safety-net community health centers evaluates the clinical performance of the 2015 USPSTF diabetes screening criteria in a minority-predominant patient population.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Bowen ME, Merchant Z, Abdullah K, Bhat D, Fish J, Halm EA. Patient, provider, and system factors associated with failure to follow-up elevated glucose results in patients without diagnosed diabetes. Health Serv Res Manag Epidemiol. 2017;4:2333392817721647. https://doi.org/10.1177/2333392817721647.

    Article  PubMed  PubMed Central  Google Scholar 

  44. •• Bowen ME, Xuan L, Lingvay I, Halm EA. Random blood glucose: a robust risk factor for type 2 diabetes. J Clin Endocrinol Metab. 2015;100(4):1503–10. https://doi.org/10.1210/jc.2014-4116. This study uses NHANES data to describe the association between non-diagnostic random glucose values and undiagnosed type 2 diabetes and prediabetes in the U.S. population.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Bowen ME, Xuan L, Lingvay I, Halm EA. Doc, I just ate: interpreting random blood glucose values in patients with unknown glycemic status. J Gen Intern Med. 2018;33(2):142–4. https://doi.org/10.1007/s11606-017-4213-9.

    Article  PubMed  Google Scholar 

  46. Bowen ME, Sanders J, Zhang S, Santini NO, Lingvay I, Halam E. Derivation of an EMR-based dysglycemia risk score. Diabetes. 2018;67(Supplement 1) https://doi.org/10.2337/db18-1497-P.

    Article  Google Scholar 

  47. • Selvin E, Wang D, Matsushita K, Grams ME, Coresh J. Prognostic implications of single-sample confirmatory testing for undiagnosed diabetes: a prospective cohort study. Ann Intern Med. 2018; https://doi.org/10.7326/M18-0091. This study supports the concurrent measurement of hemoglobin A1c and fasting glucose on a single blood sample to identify undiagnosed diabetes and confirm diagnosis.

    Article  Google Scholar 

  48. Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet. 2012;380(9855):1741–8. https://doi.org/10.1016/s0140-6736(12)61422-6.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Law M. "Opportunistic" screening. J Med Screen. 1994;1(4):208.

  50. Whitley HP, Hanson C, Parton JM. Systematic diabetes screening using point-of-care HbA1c testing facilitates identification of Prediabetes. Ann Fam Med. 2017;15(2):162–4. https://doi.org/10.1370/afm.2035.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Herman WH, Taylor GW, Jacobson JJ, Burke R, Brown MB. Screening for prediabetes and type 2 diabetes in dental offices. J Public Health Dent. 2015;75(3):175–82. https://doi.org/10.1111/jphd.12082.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Krass I, Carter R, Mitchell B, Mohebbi M, Shih STF, Trinder P, et al. Pharmacy diabetes screening trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. BMJ Open. 2017;7(12):e017725. https://doi.org/10.1136/bmjopen-2017-017725.

    Article  PubMed  PubMed Central  Google Scholar 

  53. • Siu AL. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163(11):861–8. https://doi.org/10.7326/m15-2345. This paper is the full report outlining the most recent diabetes screening guideline by the USPSTF.

    Article  PubMed  Google Scholar 

  54. Piper MA, Evans CV, Burda BU, Margolis KL, O'Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. preventive services task force. Ann Intern Med. 2015;162(3):192–204. https://doi.org/10.7326/m14-1539.

    Article  PubMed  Google Scholar 

  55. Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program? Health Aff (Millwood). 2012;31(1):67–75. https://doi.org/10.1377/hlthaff.2011.1009.

    Article  Google Scholar 

  56. Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis. Diabetes Care. 2014;37(4):922–3. https://doi.org/10.2337/dc13-2195/-/DC1.

    Article  PubMed  Google Scholar 

  57. Mudaliar U, Zabetian A, Goodman M, Echouffo-Tcheugui JB, Albright AL, Gregg EW, et al. Cardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysis. PLoS Med. 2016;13(7):e1002095. https://doi.org/10.1371/journal.pmed.1002095.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Haw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, et al. Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2017;177(12):1808–17. https://doi.org/10.1001/jamainternmed.2017.6040.

    Article  PubMed  Google Scholar 

  59. Azar KM, Xiao L, Ma J. Baseline obesity status modifies effectiveness of adapted diabetes prevention program lifestyle interventions for weight management in primary care. Biomed Res Int. 2013;2013:191209–7. https://doi.org/10.1155/2013/191209.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Sepah SC, Jiang L, Peters AL. Translating the diabetes prevention program into an online social network: validation against CDC standards. Diabetes Educ. 2014;40(4):435–43. https://doi.org/10.1177/0145721714531339.

    Article  PubMed  Google Scholar 

  61. Trief PM, Weinstock RS, Cibula D, Delahanty LM. Sustained weight loss one year after group telephone intervention: 3-year results from the SHINE study. Diabetes Res Clin Pract. 2014;106(3):e74–8. https://doi.org/10.1016/j.diabres.2014.09.032.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Chen F, Su W, Becker SH, Payne M, Castro Sweet CM, Peters AL, et al. Clinical and economic impact of a digital, remotely-delivered intensive behavioral counseling program on Medicare beneficiaries at risk for diabetes and cardiovascular disease. PLoS One. 2016;11(10):e0163627. https://doi.org/10.1371/journal.pone.0163627.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Vadheim LM, Patch K, Brokaw SM, Carpenedo D, Butcher MK, Helgerson SD, et al. Telehealth delivery of the diabetes prevention program to rural communities. Transl Behav Med. 2017;7(2):286–91. https://doi.org/10.1007/s13142-017-0496-y.

    Article  PubMed  PubMed Central  Google Scholar 

  64. LeFevre ML, U. S. Preventive services task force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;161(8):587–93. https://doi.org/10.7326/M14-1796.

    Article  PubMed  Google Scholar 

  65. Diabetes Prevention Program Research Group. The diabetes prevention program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22(4):623–34.

    Article  Google Scholar 

  66. Marrero DG, Palmer KN, Phillips EO, Miller-Kovach K, Foster GD, Saha CK. Comparison of commercial and self-initiated weight loss programs in people with Prediabetes: a randomized control trial. Am J Public Health. 2016;106(5):949–56. https://doi.org/10.2105/ajph.2015.303035.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the US: the National Diabetes Prevention Program. Am J Prev Med. 2013;44(4):S346–S51.

    Article  Google Scholar 

  68. Vojta D, Koehler TB, Longjohn M, Lever JA, Caputo NF. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program. Am J Prev Med. 2013;44(4 Suppl 4):S301–6. https://doi.org/10.1016/j.amepre.2012.12.018.

    Article  PubMed  Google Scholar 

  69. YMCA's Diabetes Prevention Program. Diabetes prevention program FACT SHEET: January 2018. YMCA of the USA: Chicago, IL; 2018.

    Google Scholar 

  70. Center for Disease Control and Prevention. National Diabetes Prevention Program. U.S. Department of Health and Human Services, Atlanta, GA. 2018. https://www.cdc.gov/diabetes/prevention/index.html. Accessed July 31 2018.

  71. • Ely EK, Gruss SM, Luman ET, Gregg EW, Ali MK, Nhim K, et al. A national effort to prevent type 2 diabetes: participant-level evaluation of CDC's national diabetes prevention program. Diabetes Care. 2017;40(10):1331–41. https://doi.org/10.2337/dc16-2099. This study analyzed data from 14,747 participants in the DPP nationwide, including those who enrolled from 2012-2016.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Vanderwood KK, Hall TO, Harwell TS, Butcher MK, Helgerson SD. Implementing a state-based cardiovascular disease and diabetes prevention program. Diabetes Care. 2010;33(12):2543–5. https://doi.org/10.2337/dc10-0862.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Brokaw SM, Carpenedo D, Campbell P, Butcher MK, Furshong G, Helgerson SD, et al. Effectiveness of an adapted diabetes prevention program lifestyle intervention in older and younger adults. J Am Geriatr Soc. 2015;63(6):1067–74. https://doi.org/10.1111/jgs.13428.

    Article  PubMed  Google Scholar 

  74. Moin T, Damschroder LJ, AuYoung M, Maciejewski ML, Datta SK, Weinreb JE, et al. Diabetes prevention program translation in the veterans health administration. Am J Prev Med. 2017;53(1):70–7. https://doi.org/10.1016/j.amepre.2016.11.009.

    Article  PubMed  Google Scholar 

  75. Tseng E, Yeh HC, Maruthur NM. Metformin use in Prediabetes among U.S. adults, 2005-2012. Diabetes Care. 2017;40(7):887–93. https://doi.org/10.2337/dc16-1509.

    Article  PubMed  PubMed Central  Google Scholar 

  76. •• Schmittdiel JA, Gopalan A, Lin MW, Banerjee S, Chau CV, Adams AS. Population health management for diabetes: health care system-level approaches for improving quality and addressing disparities. Curr Diab Rep. 2017;17(5):31. https://doi.org/10.1007/s11892-017-0858-3. This narrative review highlights the role of several strategies to improve population-level management of type 2 diabetes, including electronic health record tools, practice redesign, and new payment models.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Moin T, Li J, Duru OK, Ettner S, Turk N, Keckhafer A, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med. 2015;162(8):542–8. https://doi.org/10.7326/M14-1773.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Desai JR. Reducing CV Risk in Prediabetes patients using EHR-based decision support. National Institutes of Health, U.S. Department of Health and Human Services, Research Portfolio Online Reporting Tools. 2018. https://projectreporter.nih.gov/project_info_description.cfm?aid=9327055&icde=40170194. Accessed July 31 2018.

  79. National Association of Chronic Disease Directors (NACDD), Leavitt Partners L. Advancing Chronic Disease Prevention and Management Programs: Building a Third-Party Organization to Support Managed Care Coverage of Services in Community-Based Organizations in Illinois. Atlanta, GA 2018.

  80. • Nowinski Konchak J, Moran MR, O’Brien MJ, Kandula NR, Ackermann RT. The state of diabetes prevention policy in the USA following the Affordable Care Act. Curr Diab Rep. 2016;16(6):55. https://doi.org/10.1007/s11892-016-0742-6. This paper highlighted all provisions of the Affordable Care Act that may promote diabetes prevention, including gaps and opportunities in current practice.

    Article  PubMed Central  Google Scholar 

Download references

Acknowledgments

Dr. Bowen is supported by NIDDK K23-DK104065 and the Dedman Family Scholars in Clinical Care. Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. Dr. O’Brien is supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (R21-DK112066). The content of this article is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health. Dr. Kullgren is a VA HSR&D Career Development awardee at the Ann Arbor VA. He is supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.

Author information

Authors and Affiliations

  1. Division of General Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390-9169, USA

    Michael E. Bowen

  2. Division of Outcomes and Health Services Research, University of Texas Southwestern Medical Center, Dallas, TX, USA

    Michael E. Bowen

  3. Kaiser Permanente Division of Research, Oakland, CA, USA

    Julie A. Schmittdiel

  4. VA Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA

    Jeffrey T. Kullgren

  5. University of Michigan Medical School, Ann Arbor, MI, USA

    Jeffrey T. Kullgren

  6. Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Ronald T. Ackermann & Matthew J. O’Brien

  7. Northwestern University Institute for Public Health and Medicine, Chicago, IL, USA

    Ronald T. Ackermann & Matthew J. O’Brien

Authors
  1. Michael E. Bowen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie A. Schmittdiel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeffrey T. Kullgren
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ronald T. Ackermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Matthew J. O’Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael E. Bowen.

Ethics declarations

Conflict of Interest

Michael E. Bowen, Julie A. Schmittdiel, Ronald T. Ackermann, and Matthew J. O’Brien declare that they have no conflict of interest. Jeffrey T. Kullgren has received consulting fees from SeeChange Health and HealthMine, and a speaking honorarium from AbilTo, Inc.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Health Care Delivery Systems and Implementation in Diabetes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bowen, M.E., Schmittdiel, J.A., Kullgren, J.T. et al. Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults. Curr Diab Rep 18, 104 (2018). https://doi.org/10.1007/s11892-018-1090-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-018-1090-5

Keywords

Search

Navigation